Highly rated in
Highly rated in
Check Dr. Russell E. Ware's experience treating your condition:
About Dr. Russell E. Ware

Russell Ware is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in Cincinnati, Ohio. Ware has been practicing medicine for over 32 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. He is licensed to treat patients in Ohio. Ware is currently accepting new patients.

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 12 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Russell E. Ware it is best to call his office and ask if your insurance is accepted.

Dr. Russell E. Ware accepts the following insurance:

  •  Ambetter
  •  CareSource

Call to see if your plan is accepted.
3333 Burnet Ave, Cincinnati, OH 45229
Background & Education
Graduate Institution
Duke University School Of Medicine, 1991
Pediatric Hematology Oncology
Pediatric Hematology-Oncology in OH
Hospital Affiliations
Cincinnati Childrens Burnet Campus
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

EXpanding Treatment for Existing Neurological Disease (EXTEND)
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Stroke Avoidance for Children in REpublica Dominicana (SACRED): A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Antibody Detection of Vaccine-Induced Secretory Effects
Repeated Employee Testing for Understanding Our Recovery to Normal
Serology to Covid for Recording Exposures and Evaluating Needs (SCREEN)
Realizing Effectiveness Across Continents With Hydroxyurea (REACH): A Phase I/II Pilot Study Of Hydroxyurea For Children With Sickle Cell Anemia
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
Hydoxyurea Exposure in Lactation: A Pharmacokinetics Study (HELPS)
Stroke With Transfusions Changing to Hydroxyurea
View 10 Less Clinical Trials -

188 Total Publications

Blood diseases in Africa: Redressing unjust disparities is an urgent unmet need.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors